HHS said it would terminate Women’s Health Initiative, then reconsidered

George Weiner: Cancer centers are special, as are site visits in CCSG review

The cancer center program of the NCI is a success that is admired not only within the NIH but worldwide. This is due, in large part, to the cancer center review process that has evolved and strengthened over the years.

Cyber-iconoclast Vinay Prasad named head of FDA’s CBER
An oncologist, Prasad has criticized accelerated approval, next-gen sequencing, and targeted therapies

Vinay Prasad, a MAHA-aligned hematologist-oncologist with an avid cyber following, was named director of the FDA Center for Biologics Evaluation and Research, where he will be responsible for the agency’s regulation of vaccines and biologics, including cell and gene therapies.

May 09, 2025

Vol.51 No.18

By Claire Marie Porter

Cancer Policy

Bhattacharya cancels NIH all-hands meeting

In an interview with Science, NIH Director Jay Bhattacharya said that his time at the NIH has been a “tough period”—especially for him.

NIH to update policies and practices, halting subawards to foreign entities

In a statement issued on May 1, NIH said it’s immediately halting most new grant awards to foreign partners working in US-led research consortia.

May 09, 2025

Vol.51 No.18

By Claire Marie Porter

Cancer Policy

Women’s Health Initiative funding officially restored

On April 21, investigators with the Women’s Health Initiative were notified that HHS planned to terminate the WHI Regional Center contracts at the end of the current fiscal year (The Cancer Letter, April 20, 2025).

May 09, 2025

Vol.51 No.18

By Claire Marie Porter

Cancer Policy

AACR calls on Congress to reject Trump’s FY2026 budget request for NIH

The American Association for Cancer Research called on Congress to stand up in unified opposition to President Trump’s FY2026 budget proposal for NIH, and to instead allocate a robust funding increase to $51.3 billion for the NIH (The Cancer Letter, May 2, 2025).

May 09, 2025

Vol.51 No.18

By Jacquelyn Cobb

HHS said it would terminate Women’s Health Initiative, then reconsidered

YOU MAY BE INTERESTED IN

George Weiner: Cancer centers are special, as are site visits in CCSG review

Cyber-iconoclast Vinay Prasad named head of FDA’s CBER
An oncologist, Prasad has criticized accelerated approval, next-gen sequencing, and targeted therapies

Bhattacharya cancels NIH all-hands meeting

NIH to update policies and practices, halting subawards to foreign entities

Women’s Health Initiative funding officially restored

AACR calls on Congress to reject Trump’s FY2026 budget request for NIH

Renew today!

Subscriber content

Never miss an issue!

Login

HHS said it would terminate Women’s Health Initiative, then reconsidered

YOU MAY BE INTERESTED IN

George Weiner: Cancer centers are special, as are site visits in CCSG review

Cyber-iconoclast Vinay Prasad named head of FDA’s CBERAn oncologist, Prasad has criticized accelerated approval, next-gen sequencing, and targeted therapies

Bhattacharya cancels NIH all-hands meeting

NIH to update policies and practices, halting subawards to foreign entities

Women’s Health Initiative funding officially restored

AACR calls on Congress to reject Trump’s FY2026 budget request for NIH

Never miss an issue!

Login

Cyber-iconoclast Vinay Prasad named head of FDA’s CBER
An oncologist, Prasad has criticized accelerated approval, next-gen sequencing, and targeted therapies